SIV sequencing for Grunst et al, ADCC protection

Plasma SIVmac239 was sequenced from NHP that were treated with PGT145 or a control antibody to determine if ADCC was sufficient for protection against SIV.

SIVmac239血浆从经PGT145或对照抗体处理的非人灵长类动物（Non-Human Primate，NHP）中获取并完成测序，以探究抗体依赖的细胞介导的细胞毒性作用（Antibody-Dependent Cell-mediated Cytotoxicity，ADCC）是否足以提供针对猴免疫缺陷病毒（Simian Immunodeficiency Virus，SIV）的保护作用。